Developments in CAR T-cell Therapy

Get up to date on menin inhibitors, an emerging class of targeted therapies for acute myeloid leukemia (AML). Menin is a key component of the KMT2A (lysine methyltransferase 2A, formerly MLL1) complex, which plays a critical role in gene regulation, development, and cell cycle co ...  Show more

Get up to date with the EHA–ESMO guidelines on Human immunodeficiency virus (HIV)-associated Lymphomas. In this episode, Prof. Kai Hubel, a key author of the guidelines, explains the importance of having dedicated recommendations for patients with HIV-associated lymphomas. He beg ...  Show more

Join Dr. Jerry Yoo as he sits down with Dr. Tom Buchheit, Director of the Regenerative Pain Therapies Program at Duke University. In this episode, Dr. Buchheit shares insights into how regenerative medicine and regenerative physical therapy can potentially spare individuals f ...

When I first had Mark Dixon on the podcast, way back in Session 14, we poked some fun at the notion that principles of Acceptance and Commitment Therapy, on the surface, didn't meet many of the 7 dimensions of Applied Behavior Analysis. Well, in Session 50, I'm joined by Dr. Jona ...  Show more

If you are wondering about the future role of AI in clinical care, this is an episode you must listen to. In this episode co-hosted with MohammadAli Jardaly, we discuss with the integration of AI into clinical care with Dr. Hussain Ismaeel (who is the co-founder of Healtech). ...

In this week’s episode, we pause from our discussion about DLBCL to talk about the fundamentals of CAR-T, BiTE and autologous transplants, which will lay the foundation for subsequent discussions about DLBCL. These therapies are the talk ...